Allogeneic T Cells Genetically Modified With A Retroviral Vector Encoding For A Truncated Form Of The Human Low Affinity Nerve Growth Factor Receptor (Deltalngfr) And The Herpes Simplex I Virus Thymidine Kinase (Hsv-Tk Mut2)

CHEMBL5315097 Phase 4 Одобрено Unknown
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

These are donor T cells genetically engineered to carry a built-in safety switch in the form of the herpes simplex virus thymidine kinase gene, which makes the cells vulnerable to the antiviral drug ganciclovir if they need to be eliminated. This approach allows the therapeutic immune cells to be safely destroyed if they cause unacceptable side effects such as graft-versus-host disease after transplantation.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Часто задаваемые вопросы

These are donor T cells genetically engineered to carry a built-in safety switch in the form of the herpes simplex virus thymidine kinase gene, which makes the cells vulnerable to the antiviral drug ganciclovir if they need to be eliminated. This approach allows the therapeutic immune cells to be safely destroyed if they cause unacceptable side effects such as graft-versus-host disease after transplantation.

Yes, Allogeneic T Cells Genetically Modified With A Retroviral Vector Encoding For A Truncated Form Of The Human Low Affinity Nerve Growth Factor Receptor (Deltalngfr) And The Herpes Simplex I Virus Thymidine Kinase (Hsv-Tk Mut2) is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL5315097. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Медицинский отказ от ответственности

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.